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Abstract
Background: Synthetic glucocorticoids such as dexamethasone (DEX) are commonly used to promote fetal lung
maturation in at-risk preterm births, but there is emerging evidence of subsequent neurobehavioral abnormalities
in these children e.g. problems with inattention/hyperactivity. However, molecular pathways mediating effects of
glucocorticoid overexposure on motor and cognitive development are poorly understood.
Methods: In this study with common marmoset monkeys, we investigated for neonatal and adulthood effects of
antenatal DEX treatment on the expression of the corticosteroid receptors and also calcyon, a risk gene for
attention-deficit/hyperactivity disorder, in the prefrontal cortex (PFC). Pregnant marmosets were exposed to DEX
(5 mg/kg body weight) or vehicle during early (days 42-48) or late (days 90-96) stages of the 144-day pregnancy.
Results: In neonates, relative to controls, glucocorticoid receptor (GR) mRNA levels were significantly reduced after
the late DEX treatment in the medial, orbital and dorsal PFC and after the early DEX treatment in the dorsal PFC.
The early DEX exposure, specifically, resulted in significant reduction in calcyon mRNA expression in the medial,
orbital, dorsal and lateral PFC relative to controls. Mineralocorticoid receptor (MR) mRNA levels were not
significantly affected by DEX treatment. In adults, PFC GR, calcyon, and MR mRNA levels were not significantly
affected by early or late prenatal DEX treatment.
Conclusion: These findings indicate that antenatal DEX treatment could lead to short-term alterations in PFC
expression of the GR and calcyon genes, with possible neurodevelopmental functional consequences.
Background
Epidemiological studies indicate that children exposed
to elevated levels of glucocorticoids during fetal life
because of maternal stress during pregnancy have an
increased risk of developing hyperactivity and cognitive
deficits, e.g., attention-deficit/hyperactivity disorder
(ADHD) [1,2]. In spite of this potential risk, synthetic
glucocorticoids such as dexamethasone (DEX) and beta-
methasone are widely used during pregnancy to prevent
respiratory distress syndrome in preterm infants. The
pulmonary benefits are undisputed, but there is growing
concern that the use of repeated courses of
glucocorticoids prenatally could disturb normal brain
development [3]. This is because the human fetal brain
expresses glucocorticoid receptors (GR) and synthetic
glucocorticoids could therefore target the developing
brain and contribute to behavioural disturbances [4].
This hypothesis is consistent with a study conducted in
school-aged children who received three or more
courses of antenatal betamethasone, which found that
such treatments are associated with an increased risk of
postnatal aggressive/destructive behaviour, increased dis-
tractibility, and hyperactivity [5]. Recently, we demon-
strated that prenatal exposure to DEX in a primate, the
common marmoset, had an impact on social develop-
ment, skilled motor reaching/dexterity, motivational and
learning functions [6]. Overall, these findings suggest
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functioning of critical brain circuits involved in cogni-
tion and behaviour.
The molecular pathways that could mediate the causal
relationship between prenatal stress or glucocorticoid
overexposure and development of neurobehavioral pro-
blems in children/adolescents remain poorly understood.
Several susceptibility alleles have been shown to be asso-
ciated with the risk of developing ADHD [7], and other
psychiatric disorders [8], where motor and cognitive
functions are often disrupted. There is only very limited
information about whether prenatal glucocorticoid over-
exposure affects the expression of these risk genes.
Recently, gene linkage and association studies have impli-
cated the region of chromosome 10q, which contains the
calcyon locus, with both the hyperactive/impulsive and
inattentive symptoms of ADHD [9,10]. This association
is supported by animal studies (e.g. using genetically
engineered mice) showing the involvement of calcyon in
the regulation of behavioral functions which are compro-
mised in ADHD [11-13]. Anatomical studies have
demonstrated that calcyon is highly expressed in multiple
brain regions, including the prefrontal cortex (PFC), in
both non-human primates and rodents [14,15]. The PFC
is involved in mediating numerous cognitive-executive
functions, e.g. working memory, decision-making, inhibi-
tory response control, and attentional set-shifting, of cen-
tral relevance to ADHD [16].
Within the framework of a multi-centre in vivo-ex
vivo study of the effects of prenatal DEX exposure on
offspring development in a nonhuman primate (Gluco-
corticoid Hormone Programming in Early Life and Its
Impact on Adult Health, EUPEAH), the present study
was conducted in the common marmoset (Callithrix
jacchus) to investigate the effects of prenatal DEX on
gene expression in the PFC. Two developmental stages
were studied, namely neonate and adult. The genes stu-
died were GR, the non-DEX sensitive mineralocorticoid
receptor (MR), and calcyon. DEX was administered dur-
ing early (days 42-48; late first third) or late (days 90-96;
late second third) stages of the 144 day pregnancy. The
early DEX exposure is likely to target the maturational
stage of maximal neurogenesis in this primate [17], and
therefore a putative sensitive period for inducing acute
central effects of prenatal glucocorticoid overexposure
(e.g. under maternal stress) with long-term conse-
quences. The late DEX exposure is within the time-win-
dow when synthetic glucocorticoids are administered to
pregnant women at risk of preterm delivery, and there-
fore of particular translational relevance. In humans, the
accepted treatment schedules for a complete single
course of antenatal corticosteroids are either two injec-
tions of betamethasone (12 mg) 24 hours apart, or four
injections of DEX (6 mg) 12 hours apart [18]. Therefore,
the regimen schedule of DEX used in the present study
might be relevant to the use of multiple courses of
antenatal corticosteroids in clinical practice.
Methods
Subjects
The common marmosets studied were bred at the
Laboratory for Behavioural Neurobiology, Swiss Federal
Institute of Technology Zurich, as described previously
[6,19]. While twinning is the norm in this species, more
than 50% of breeding females have litters of 3 neonates
in captivity. Natural rearing of all three triplets is gener-
ally not possible and without intervention the weakest
young dies some days after birth. Therefore, in triplet
litters one neonate was euthanized on postnatal day 2
and these subjects were used to investigate the effects of
prenatal DEX at the neonatal stage. For the present
study, there were three neonates per treatment group,
with each neonate derived from a different breeding
pair. The sex of the neonates was: VEH: 3 males; EDEX:
3 males; LDEX: 1 female, 2 males. The surviving twin
offspring per birth were used to investigate the long-
term effects of DEX on physical growth, hypothalamic-
pituitary-adrenal (HPA) axis, social behaviour, and
neuropsychological function, from infancy to young
adulthood, as described previously [6,19]. These subjects
were euthanized at age 18-20 months and brains and
other organs were collected. For the present study there
were 6 VEH adults (3 female, 3 male), 6 EDEX adults
(3 female, 3 male) and 6 LDEX adults (3 female, 3
male). The in vivo studies were conducted under experi-
mental permit in accordance with the Swiss Animal
Protection Act (1978). The brain tissues were shipped to
Stockholm for study under license from the Convention
for International Trade in Endangered Species of Wild
Fauna and Flora (CITES), administered by the Swiss
Federal Office for Veterinary Affairs and the Swedish
Department of Agriculture.
Prenatal DEX treatment
The common marmoset has a fully functional hypotha-
lamic-pituitary-adrenal (HPA) axis, and exhibits rela-
tively high physiological basal cortisol concentrations
[20]. To determine a suitable treatment dose of DEX, a
pilot study was conducted at the German Primate Cen-
ter in which pregnant marmosets were treated with a
range of doses of DEX, between 0.05 mg/kg and 10 mg/
kg per day orally. Dexamethasone (0.5, 1.5 or 4 mg,
Jenapharm®, Jena, Germany) was dissolved in 0.4 mL tap
water and mixed with 1.6 mL NutiCal® (Albrecht,
Aulendorf, Germany). The mixture was taken voluntarily
by all animals. 1 mg/kg or 5 mg/kg DEX per day was
found to effectively suppress maternal endogenous corti-
sol production without adverse effects, whilst 10 mg/kg
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coid deficiency after cessation of treatment. The 5 mg/
kg dose of DEX was used in all subsequent experiments
and administered at the same time of day (09:00 h) to
all pregnant females in the study. This dose is signifi-
cantly higher than those shown to produce program-
ming effects in rodents [21] or vervet monkeys [22], and
reflects the relative resistance of the marmoset to gluco-
corticoid action [20]. Briefly, pregnant marmosets (n = 4
females per group) were allocated randomly to one of
the treatment groups and were administered DEX
(5 mg/kg) or syrup vehicle, during estimated gestation
days 42-48 (early DEX, EDEX) and 90-96 (late DEX,
LDEX) of the 144-day gestation period, as follows:
vehicle (VEH at both treatment windows), early DEX
(EDEX, and VEH late), late DEX (VEH early and
LDEX), as described previously [6,19].
Tissue collection and in situ hybridization
At 1400 h, a subject was removed from its home cage to
a procedures room and sedated; deep anaesthesia was
followed by rapidly removin gt h eb r a i nf r o mt h es k u l l
and freezing in isopentane on dry ice at -40°C, and stor-
ing at -80°C. Brains were coronally sectioned in a cryo-
stat at 20 μm thickness and prepared for in situ
hybridization technique (ISH). For GR and MR, we used
common marmoset-specific riboprobes that have been
previously described [23]. For calcyon, a new riboprobe
was prepared by amplifying a conserved region of cal-
cyon (GenBank: AF225903, 301-660) from a human
brain cDNA library. The amplified cDNA fragment was
subcloned into a pCR1II-TOPO vector (Invitrogen,
Lidingö, Sweden), and confirmed by nucleotide sequen-
cing. Linearized plasmids were used to synthesize [
35S]
UTP-labeled riboprobes. In-vitro transcription was car-
ried out using the MAXIscript™ SP6/T7 kit (Applied
Biosystems, Uppsala, Sweden) and [a35-S]UTP
(NEG039H; Perkin Elmer, Upplands Väsby, Sweden)
according to the manufacturer’s instructions. The tran-
scripts were purified using NucAway™ spin columns
(Applied Biosystems, Uppsala, Sweden). Fixation, pre-
hybridization, hybridization and washes were performed
as previously described [12].
In situ hybridization was conducted with sections
from the intermediate PFC, using two adjacent sections
per subject. For each probe, all sections for the same
age group were included in a single ISH run. Controls
comprised concurrent hybridization with sense strand
probes. The sections were exposed to autoradiographic
film (BIOMAX, Kodak) for 1-2 weeks to enable visuali-
zation of GR-, MR- and calcyon-hybridization. Cali-
brated [
14C]-labelled standards (Amersham Biosciences,
Uppsala, Sweden) were incorporated in all cassettes to
allow for quantification.
Image and data analysis
Films were scanned with an Epson Perfection 4990
scanner as grey scale film, using 800 pixels and saved as
high-quality JPEGs. Optical density values were quanti-
fied using appropriate software (NIH Image J version
1.29, U.S. National Institutes of Health, Bethesda, MD,
USA). The following PFC regions were identified
according to [24]: medial, orbital, dorsal and lateral. In
each region, signals were measured over the two adja-
cent sections per subject and the mean value per subject
was used for statistical analysis. For each gene, the
effects of prenatal DEX treatment were first studied in a
mixed-model ANOVA that included developmental
stage (neonate, adult) as a between-subjects factor.
ANOVA was then performed for each developmental
stage separately using a two-stage approach: Firstly, a
mixed ANOVA with PFC subregion and hemisphere as
within-subjects factor, and treatment (VEH, EDEX and
LDEX) as between-subject factor. Where mixed
ANOVA revealed a main effect of treatment or a treat-
ment × subregion interaction, treatment differences
were examined in each subfield separately using univari-
ate ANOVA. Significant main effects were followed up
post hoc using the Bonferroni/Dunn test. All but one
neonate was male. Sex was included as a factor in the
adult ANOVA and as there were no significant effects
of sex, sex is not reported on as a factor in the Results.
For all analyses, significance was assigned at the
P < 0.05 level. All data are presented as means ± S.E.M.
Results
Effects of prenatal DEX on anthropometric parameters
in neonates
As found in earlier studies [19], in two-day-old monkeys
there were no significant effects of prenatal DEX on
body weight (g), (VEH: 27.6 ± 1.3, EDEX: 27.8 ± 0.7,
LDEX: 26.1 ± 1.3; P > 0.1) or knee-heel length (mm)
(VEH: 26 ± 0, EDEX: 26 ± 0.6, LDEX: 26 ± 0.6; P > 0.1).
Effects of prenatal DEX on calcyon, GR and MR mRNA
expression
Each transcript was detected (Figs. 1, 2) in both neonate
and adult PFC. The specificity of signal was confirmed
using sense probes, which did not produce any signals
(see Additional file 1). It is worth mentioning that we
also tested the specificity of the calcyon probe using
human brain tissue: here also the sense probe produced
negligible signals (R. Diaz Heijtz and T. Hökfelt, unpub-
lished data). Hemisphere was included as a factor in the
analyses and as there were no significant effects of hemi-
spheres, hemisphere is not reported as a factor in the
Results. In all genes studied, the ANOVA of age group
(neonate, adult) × treatment (VEH, EDEX, LDEX) × PFC
subregion yielded a significant main effect of age
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teriori ANOVAs were then performed separately for
neonates and adults, reported below.
Neonatal PFC
For GR mRNA, mixed ANOVA revealed a significant
treatment-by-PFC subregion interaction (F (6, 45) = 2.5,
P = 0.0375), and significant main effects of treatment
(F (2, 15) = 14.5, P = 0.0003) and PFC subregion
(F (3, 45) = 23.1, P < 0.0001). Subsequent analysis
showed that GR mRNA (Figs. 3A and 4) was signifi-
cantly affected by prenatal DEX treatment in the medial
(F(2,15) = 28.3, P < 0.001), orbital (F(2,15) = 8.2,
P = 0.004), and dorsal (F(2,15) = 7.7, P = 0.005) PFC.
Post-hoc analysis showed that LDEX neonates expressed
Figure 1 Representative autoradiograms showing calcyon, GR and MR mRNAs in PFC of neonate marmoset monkeys. A. Low-power
scan of a cresyl violet-stained coronal section taken from an intermediate level of the marmoset frontal lobes (left). The approximate boundaries
used to delineate the medial, dorsal, lateral and orbital PFC subregions are indicated with dotted lines (right). B. Calcyon mRNA expression.
C. GR mRNA expression. D. MR mRNA expression. Scale bar = 4 mm.
Figure 2 Representative autoradiograms showing calcyon, GR and MR mRNAs expression in PFC of adult marmoset monkeys.
A. Low-power scan of a cresyl violet-stained coronal section taken from an intermediate level of the marmoset frontal lobes (left). The
approximate boundaries used to delineate the medial, dorsal, lateral and orbital PFC subregions are indicated with dotted lines (right).
B. Calcyon mRNA expression. C. GR mRNA expression. D. MR mRNA expression. Scale bar = 4 mm.
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medial and orbital PFC when compared to VEH neo-
nates. In the dorsal PFC both EDEX and LDEX neo-
nates expressed significantly (P < 0.05) lower levels of
GR mRNA than the VEH neonates.
In the case of MR mRNA there were no significant
main or interaction effects (P > 0.05) (Table 1).
For calcyon mRNA, mixed ANOVA revealed signifi-
cant main effects of treatment (F (2, 15) = 6.1,
P = 0.0116) and PFC subregion (F (3, 45) = 37.8,
P < 0.0001). Subsequent analysis showed that calcyon
mRNA (Figs. 5A and 6) was significantly affected by
prenatal DEX treatment in the medial (F(2,15) = 7.1, P
= 0.007), orbital (F(2,15) = 4.2, P = 0.035), dorsal
(F(2,15) = 5.5, P = 0.016), and lateral (F(2,15) = 4.0,
P = 0.041) PFC. Post-hoc analysis with Bonferroni/Dunn
test showed that in the medial, orbital, dorsal and lateral
PFC, EDEX neonates expressed significantly (P < 0.05)
lower levels of calcyon mRNA compared to VEH neo-
nates. The mean decrease in calcyon mRNA expression
in LDEX neonates was not significant.
Adult PFC
For GR, MR and calcyon mRNAs, there was no siginificant
effect of treatment in adult subjects. For GR (Fig. 3B),
repeated ANOVA revealed significant PFC subregional
differences in mRNA expression (F (3,99) = 87.9, P <
0.0001); with the lPFC and mPFC expressing the highest
and lowest mRNA levels, respectively. For MR (Table 1),
repeated ANOVA revealed significant PFC subregional
differences in expression (F (3, 81) = 84.5, P < 0.0001);
with the lPFC and dPFC subregions expressing the highest
m R N Al e v e l s .I nt h ec a s eo fc a l c y o n( F i g .5 B ) ,r e p e a t e d
ANOVA revealed significant PFC subregional differences
Figure 3 Prenatal DEX effects on the expression of GR mRNA in PFC. PFC subregion-specific densities are presented (mean ± S.E.M.) for
neonate (A) and adult (B) monkeys. **P < 0.001, * P < 0.05 when compared to VEH of the same PFC region.
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the mPFC subregion expressing the highest mRNA levels.
Discussion
This study describes the effects of prenatal DEX treat-
ment on gene expression in the PFC, a brain region
implicated in ADHD and other psychiatric disorders, at
neonate and adult life stages. Thus, prenatal DEX expo-
sure in marmoset monkeys leads to alterations in GR
and calcyon (a risk gene for ADHD) mRNA expression
in the neonate PFC. Taken together with recent findings
(see below), the present results suggest that in non-
human primates antenatal DEX exposure might modify
the early postnatal development and synaptic plasticity
of PFC with possible functional consequences.
Studies in rodents have shown that the developing
PFC is extremely sensitive to stress, possibly including
elevated levels of stress hormones (i.e. glucocorticoids).
For example, prenatal stress in rodents leads to latera-
lized changes in PFC DA function [25,26], alterations of
PFC neuronal structure (e.g. spine density and dendritic
complexity; [27]), and long-lasting changes in some sub-
types of dopamine and glutamate receptors [27], which
are thought to underlie cognitive and emotional deficits
observed in prenatally stressed animals [26]. In humans,
maternal stress during pregnancy is associated with an
increased risk of developing ADHD-like symptoms
[1,2,26]. Moreover, antenatal exposure to multiple
courses of synthetic glucoco r t i c o i d si sa l s oa s s o c i a t e d
with increased neurobehavioral problems (e.g. aggres-
sive/destructive behaviour, increased distractibility, and
hyperactivity) in children [5,28,29]. Taken together,
these results suggest that fetal glucocorticoid overexpo-
sure leads to altered development and functioning of
PFC, a critical region involved in cognition and emo-
tional regulation.
Recently, we described the effects of prenatal DEX
exposure on behavioral traits in juvenile and adolescent
common marmosets. We showed for the first time that
exposure of the fetus to DEX has a long-term postnatal
impact on social development, skilled motor reaching/
dexterity, motivational and learning functions [6]. In the
present study, we assessed whether the same treatment
Figure 4 Representative autoradiograms showing the effects of LDEX treatment on GR mRNA expression in PFC of neonates.
Abbreviation as follows: VEH, vehicle; LDEX, late dexamethasone exposure. For more details see Fig. 1.
Table 1 MR mRNA levels (nCi/g, mean ± S.E.M.) in VEH,
EDEX and LDEX Marmosets
Prefrontal cortex subregions
medial orbital dorsal lateral
Neonates
VEH 58 ± 2.6 62 ± 4.4 65 ± 6.5 60 ± 6.9
EDEX 56 ± 1.1 54 ± 3.5 54 ± 2.4 51 ± 3.7
LDEX 61 ± 3.0 65 ± 4.3 75 ± 5.9 68 ± 5.6
Adults
VEH 166 ± 5.3 171 ± 5.4 226 ± 5.8 242 ± 7.4
EDEX 168 ± 12.9 173 ± 10.0 221 ± 17.2 229 ± 18.0
LDEX 189 ± 7.3 193 ± 7.3 244 ± 16.0 266 ± 25.5
For logistic reasons, analysis of prenatal DEX effects on prefrontal cortex
mineralocorticoid receptor (MR) was conducted with matched sections from
only 4-6 subjects/manipulation group. There were no significant main or
interaction effects of DEX (P > 0.05).
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calcyon (a risk gene for ADHD; see below) in neonate
and adult PFC. Prenatal DEX exposure, especially during
late gestation, led to significant reductions in GR
expression in the neonate PFC. The expression of MR
mRNA was not significantly affected by prenatal DEX
treatment, which is consistent with the fact that DEX
has a low affinity for the MR and selectively binds to
GR [30]. A recent study showed that in the developing
human hippocampus both GR and MR are expressed
b e t w e e n2 4a n d3 4w e e k so fg e s t a t i o n[ 3 1 ] .T h i si st h e
time-window when synthetic glucocorticoids are admi-
nistered to pregnant women at risk for preterm delivery.
Interestingly, the same study did not find an effect of
antenatal DEX treatment on GR or MR gene expression
in the human hippocampus at the third trimester of
gestation. Based upon previous work in the squirrel
monkey [32] and rhesus monkey [33] demonstrating the
relatively low expression of GR in hippocampus versus
neocortex, and the present results, we postulate that, in
primates, GR in neocortical areas are more important
potential mediators of effects of antenatal glucocorticoid
treatment than are GR in hippocampus.
One of the most interesting findings of the present
study is the observation that prenatal DEX treatment
induced a down-regulation of calcyon (a risk gene for
ADHD) gene expression in the neonate PFC. Calcyon is
a single transmembrane protein highly expressed in PFC
[12,14]. New evidence indicates a role for calcyon in cla-
thrin mediated endocytosis, a critical component of
Figure 5 Prenatal DEX effects on the expression of calcyon mRNA in PFC. PFC subregion-specific densities are presented (mean ± S.E.M.)
for neonate (A) and adult (B) monkeys. * P < 0.05 when compared to VEH of the same PFC region.
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cal findings localizing calcyon to vesicular compartments
in dendritic spines and axon terminals [35], two sites in
the brain where clathrin mediated endocytosis is essen-
tial for efficient neurotransmission and plasticity asso-
ciated with learning and memory [34]. Support for a
role of calcyon in the aetiology of ADHD comes primar-
ily from genetic studies. In a recent genome-wide link-
age study for loci influencing ADHD, the calcyon gene
was found to coincide with one of the highest positive
linkage sites identified at chromosome 10q26 [9]. More
recently, the inheritance of nine polymorphisms in the
calcyon gene was examined with ADHD and their
immediate families using the transmission disequili-
brium test [10]. This study reported evidence for excess
transmission of the most common calcyon haplotype,
designated C1. In addition, C1 was positively associated
with both hyperactive/impulsive and inattentive symp-
toms, supporting the idea that variations in calcyon may
contribute to both deficits in motor control and cogni-
tive functions of the disorder. This notion is supported
by recent animal studies demonstrating alterations in
calcyon gene expression in a genetic rat model of
ADHD [12] and ADHD-like phenotypes in calcyon
over-expressing transgenic mice [13]. In the current
study we showed that calcyon is expressed during early
postnatal development of the non-human primate PFC
and that it is sensitive to fetal glucocorticoid overexpo-
sure. These observations have marked translational sig-
nificance given the genetic link of calcyon to ADHD.
DEX is known to cause its effects by binding to the
GR [30]. Once activated, the GR subunits homodimerize
and bind to DNA via glucocorticoid responsive elements
(GREs) in the promoter region of target genes resulting
in the regulation of gene expression [36]. In addition,
GR is also involved in crosstalk with other transcription
factors, such as AP-1, CREB-binding protein, STAT5,
and NFkB (see [37]). Crosstalk between GR and these
transcription factors may occur either through compo-
site response element, overlapping response element, or
interaction between GR and transcription factors. We
used bioinformatic tools (MatInspector, Genomatix Soft-
ware GmbH) to search for the GRE consensus sequence
(consisting of the palindromic binding site AGAA-
CAnnnTGTTCT) and related elements in the human
CALY promoter. This analysis revealed that the human
CALY promoter does not contain a consensus sequence
for the GRE (see Additional file 2), suggesting that
antenatal DEX-mediated decreases in calcyon gene
expression are not likely to be a direct effect of GR
binding to the calcyon promoter. However, the CALY
promoter contains consensus sequences for the binding
of several transcription factors including Sp-1 (see Addi-
tional file 2). Interestingly, previous studies have shown
that DEX can regulate gene transcription through a
mechanism dependent on the Sp-1 transcription factor
[38], and therefore could be a potential mechanism
mediating antenatal DEX effects on calcyon gene
expression.
In our previous studies in marmoset monkeys, we
observed that the outcome of antenatal DEX exposure
on behavioral traits was dependent upon the timing of
administration i.e. EDEX versus LDEX [6,19]. In the
present study, we also observed that early and late DEX
treatments differentially affected GR and calcyon mRNA
levels in neonates, with early DEX affecting calcyon and
late DEX affecting GR. We hypothesize that the differ-
ent effects of early vs. late DEX treatment on gene
expression and behavior could originate from the differ-
ence in the stage of brain maturation (e.g. GR expres-
sion and/or transcription factors interaction with GR) at
the time of these two antenatal DEX treatments.
The absence of significant effects of antenatal DEX on
either GR or calcyon gene expression in adult PFC sug-
gests the presence of compensatory - and possibly but
not necessarily protective - mechanisms acting during
the protracted postnatal maturation of the primate PFC
[39,40]. However, it will be important to assess in future
studies potential effects of repeated antenatal glucocorti-
coid exposure on PFC gene expression and cognitive-
executive functions during the juvenile period when
ADHD-symptoms usually manifest in children.
Conclusion
In summary, in the present study we investigated the
effects of antenatal DEX treatment on the expression of
Figure 6 Representative autoradiograms showing the effects of
EDEX treatment on calcyon mRNA expression in PFC of
neonates. Abbreviation as follows: VEH, vehicle; EDEX, early
dexamethasone exposure. For more details see Fig. 1.
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ADHD, in the PFC in the common marmoset. Our
results indicate that prenatal DEX exposure led to
alterations in neonate PFC gene expression of GR and
calcyon, a risk gene for ADHD. These novel primate
findings suggest a potential molecular pathway mediat-
ing the effects of fetal glucocorticoid overexposure on
abnormal motor and cognitive development.
Additional file 1: calcyon sense RNA probe. Representative
autoradiogram showing a PFC section of neonate marmoset monkey
hybridized with calcyon sense RNA probe.
Additional file 2: Transcription binding site analysis of the human
calcyon promoter. This table shows potential transcription binding sites
in the human calcyon promoter as predicted by the MatInspector
analysis (Genomatix Software GmbH).
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